tiprankstipranks
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:1276 full AI Analyst Report?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Stock News & Sentiment

5 Followers
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
Premium
Company Announcements
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
10d ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
Premium
Company Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
10d ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
Premium
Company Announcements
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
10d ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
Premium
Company Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
10d ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
Premium
Company Announcements
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
17d ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
Premium
Company Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
22d ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
Premium
Company Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
22d ago
1276
More HK:1276 News >

1276 News on the Web

Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
TipRanks News
Neutral
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
TipRanks News
Bearish
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
TipRanks News
Neutral
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
TipRanks News
Neutral
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
TipRanks News
Neutral
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Gets a Buy from Morgan Stanley
TipRanks News
Bullish
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
TipRanks News
Neutral
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
TipRanks News
Bullish

News Score - Last 7 Days

Negative
HK:1276
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.75 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1276’s Media Buzz Sentiment?
4 articles about HK:1276 were published this week. In an average week, 1.75 articles are published.
    What is HK:1276’s weekly average amount of articles?
    In an average week, 1.75 articles about HK:1276 are published.
      What is HK:1276’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week